Alpha IVF moves to Bursa Malaysia Main Market

Alpha IVF moves to Bursa Malaysia Main Market
Alpha IVF moves to the Main Market

Alpha IVF Group Bhd’s transfer to the Bursa Malaysia Main Market marks a new step in the fertility care company’s regional expansion. The move comes as the group expands its network of IVF centres while maintaining its long-term growth targets across five countries.

Highlights

  • Alpha IVF Group Bhd moved to the Bursa Malaysia Main Market on Tuesday to strengthen its profile and broaden its investor base.
  • Alpha IVF is targeting RM1 billion in revenue within 10 years, recording a net profit of RM53.63 million and revenue of RM198.58 million for FY2026, with no borrowings.
  • Since its March 2024 listing, Alpha IVF has expanded its full-service IVF centres from three to eight, extending its presence to five countries in the region.

This article was translated from the original. Read the original version by our correspondent here.

Growth plans and financial fundamentals

As reported by The Edge Malaysia, Alpha IVF Group Bhd completed its transfer from the ACE Market to the Bursa Malaysia Main Market on Tuesday as it seeks to strengthen its corporate profile and broaden its investor base. Group managing director Datuk Dr Colin Lee Soon Soo said the move is expected to support the company’s ambition to become a regional powerhouse in in vitro fertilisation, or IVF.

In the statement, he said the group is targeting RM1 billion in revenue over the next 10 years while continuing to expand its centre capacity. He added that each new centre is viewed as a long-term investment that supports family building and a sustainable business for shareholders.

For the financial year ended 31 May 2026, Alpha IVF recorded a net profit of RM53.63 million on revenue of RM198.58 million. Total dividends declared for FY2026 were 1.10 sen per share, while as at 31 May 2026, the group had RM134.3 million in cash and short-term investments and no borrowings.

Regional footprint and clinical standards

Since its listing on the ACE Market in March 2024, Alpha IVF has expanded its network of full-service IVF centres from three to eight, extending its presence from Malaysia and Singapore to Indonesia and the Philippines. Together with three satellite clinics in Indonesia and two sales offices in China, the group’s regional network now comprises 13 facilities across five countries.

To maintain clinical standards as its network grows, the company uses a proprietary approach it calls a “system of systems”, which brings together its specialists, embryologists, and research and laboratory capabilities. This approach allows its centres to share knowledge, follow common protocols and work to consistently maintain high IVF success rates.

According to Colin Lee, the company’s new centres have already begun to replicate the high success rates achieved at its flagship centre. As the group continues to grow, its priority is to maintain clinical standards while increasing patient volumes and contributions from its new centres.

We recently wrote about TM’s undersea cable project in our review of mixed results from Bursa Malaysia-listed companies.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.